Related Experiment Video
Updated: Jun 3, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
The effect of olive oil polyphenols on antibodies against oxidized LDL. A randomized clinical trial
Olga Castañer1, Montserrat Fitó, M Carmen López-Sabater
1Cardiovascular Risk and Nutrition, Cardiovascular Epidemiology and Genetics, and Human Pharmacology and Clinical Neurosciences Research Groups, Research Institute Hospital del Mar (IMIM), Barcelona 08003, Spain.
Background & Aim:
Oxidized LDL (oxLDL) is a highly immunogenic particle that plays a key role in the development of atherosclerosis. Some data suggest a protective role of OxLDL autoantibodies (OLAB) in atherosclerosis. Our aim was to assess the effect of olive oil polyphenols on the immunogenicity of oxLDL to autoantibody generation.
Methods:
In a crossover, controlled trial, 200 healthy men were randomly assigned to 3-week sequences of 25 mL/day of 3 olive oils with high (366 mg/kg), medium (164 mg/kg), and low (2.7 mg/kg) phenolic content.
Results:
Plasma OLAB concentration was inversely associated with oxLDL (p < 0.001). Olive oil phenolic content increased OLAB generation, with the effect being stronger at higher concentrations of oxLDL (p = 0.020 for interaction). A direct relationship was observed between OLAB and the total olive oil phenol content in LDL (r = 0.209; p = 0.014). OLAB concentrations, adjusted for oxLDL, increased directly in a dose-dependent manner with the polyphenol content of the olive oil administered (p = 0.023).
Conclusion:
Olive oil polyphenols promote OLAB generation. This effect is stronger at higher concentrations of lipid oxidative damage.
Related Concept Videos
Atherosclerosis III: Management
Radical Autoxidation
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
